<DOC>
	<DOCNO>NCT02031770</DOCNO>
	<brief_summary>Cardiovascular disease ( CVD ) lead cause death patient chronic kidney disease ( CKD ) large artery damage major factor contribute death . Metabolic acidosis common complication CKD result inability diseased kidney excrete daily dietary acid load associate all-cause mortality patient CKD . However , effect treatment metabolic acidosis oral sodium bicarbonate endothelial dysfunction arterial stiffness patient CKD evaluate . The investigator propose prospective , randomize , control , open-label 14-week crossover pilot study examine effect treatment metabolic acidosis oral sodium bicarbonate vascular endothelial function 20 patient CKD stage IV metabolic acidosis .</brief_summary>
	<brief_title>Metabolic Acidosis Vascular Function Patients With Chronic Kidney Disease</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Acidosis</mesh_term>
	<criteria>Inclusion Criteria Age 4070 year CKD stage IV ( eGFR 1529 ml/min/1.73m2 ; stable renal function past 3 month ) Serum bicarbonate level &lt; 20 â‰¥ 16 meq/L ( least 2 consecutive weekly measurement ) Body mass index &lt; 40 kg/m2 ( FMD measurement inaccurate severely obese patient ) Ability give inform consent Stable antihypertensive , diabetic lipid lower regimen least one month prior randomization Significant comorbid condition lead investigator conclude life expectancy le 1 year Uncontrolled hypertension Expected undergo living relate kidney transplant next 6 month Expected start dialysis next 3 month Overt congestive heart failure Use sevelamer Use calcium carbonate</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>vascular endothelial cell</keyword>
</DOC>